Free Trial
CVE:SQD

SQI Diagnostics (SQD) Stock Price, News & Analysis

SQI Diagnostics logo
C$0.02 0.00 (0.00%)
As of 06/14/2023

About SQI Diagnostics Stock (CVE:SQD)

Key Stats

Today's Range
C$0.02
▼
C$0.02
50-Day Range
C$0.02
▼
C$0.02
52-Week Range
C$0.01
▼
C$0.18
Volume
65,000 shs
Average Volume
172,133 shs
Market Capitalization
C$6.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.

Receive SQD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SQI Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SQD Stock News Headlines

Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
Closing Bell: Sqi Diagnostics Inc flat on Friday (SQD)
Closing Bell: Sqi Diagnostics Inc up on Friday (SQD)
Closing Bell: Sqi Diagnostics Inc up on Wednesday (SQD)
Closing Bell: Sqi Diagnostics Inc down on Monday (SQD)
See More Headlines

SQD Stock Analysis - Frequently Asked Questions

SQI Diagnostics' stock was trading at C$0.02 at the beginning of the year. Since then, SQD shares have increased by 0.0% and is now trading at C$0.02.

Shares of SQD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that SQI Diagnostics investors own include Snowflake (SNOW), Meta Platforms (META), Cloudflare (NET), NVIDIA (NVDA), Royal Bank Of Canada (RY), Tempest Therapeutics (TPST) and Bank of America (BAC).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Life Sciences Tools & Services
Sub-Industry
Life Sciences Tools & Services
Current Symbol
CVE:SQD
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$19.14 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-74.70%

Debt

Debt-to-Equity Ratio
464.33
Current Ratio
0.12
Quick Ratio
0.40

Sales & Book Value

Annual Sales
C$3.04 million
Price / Sales
2.01
Cash Flow
C$0.00 per share
Price / Cash Flow
8.50
Book Value
C($0.04) per share
Price / Book
-0.38

Miscellaneous

Outstanding Shares
407,170,000
Free Float
N/A
Market Cap
C$6.11 million
Optionable
Not Optionable
Beta
-0.21
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (CVE:SQD) was last updated on 10/5/2026 by MarketBeat.com Staff.
From Our Partners